Kringle Pharma,Inc.

4884

TSE PrimePharmaceuticals

¥ -

You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.

descriptionIncome Statement (PL) Summary

Updated: 2026-08-10FY2026 Q3

Revenue

3.4100M JPY

YoY +372.4%

Operating Income

-6.3100M JPY

YoY +14.2%

Net Income

-8.1100M JPY

YoY +17.3%

EPS

-84.4JPY

YoY +22.1%

Performance Trend

Revenue, operating income and net income trend (last 5 periods)

RevenueOperatingNet Income

3.9億円

64.8百万円

-2.6億円

-5.9億円

-9.2億円

Rev: 2.9億円Op: -3.6億円NI: -3億円

Rev: 3.9億円Op: -4.3億円NI: -3.3億円

Rev: 69.3百万円Op: -8.9億円NI: -8.5億円

Rev: 80百万円Op: -8.2億円NI: -7.6億円

Rev: 72.2百万円Op: -9.1億円NI: -9.2億円

2021/FY2022/FY2023/FY2024/FY2025/FY

Full-Year Progress

FY2026 Q3

Net Income-

Revenue Progress3.200M

Revenue Forecast3.300M

Net Income Progress-

Net Income Forecast-

Income Statement Details

Unit: JPY

Unlock Long-Term Financial Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.

Standard Plan Premium Plan